Fang Yuan. "Efficacy and safety of disitamab vedotin combined with toripalimab for cisplatin-refractory advanced penile cancer: A prospective single-center study (SAVE).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.5034